Results 181 to 190 of about 86,962 (305)
Duchenne muscular dystrophy in one of monozygotic twin girls [PDF]
P.H. Jongbloet
openalex +1 more source
Exploring the Role of Telemedicine in Duchenne Muscular Dystrophy: Benefits and Challenges. [PDF]
Wasilewska E +10 more
europepmc +1 more source
ABSTRACT Background Hydrogen sulphide (H2S), a gasotransmitter synthesized by cystathionine‐γ‐lyase (CSE), exhibits antioxidant properties and may mimic exercise‐induced muscle protection. However, its mechanistic role in muscle atrophy and exercise intervention remains unclear.
Xiuru Li +5 more
wiley +1 more source
ABSTRACT Background Duchenne muscular dystrophy (DMD) is a fatal X‐linked disease caused by mutations in the DMD gene, leading to dystrophin deficiency and progressive degeneration of skeletal and cardiac muscles. Pigs lacking DMD exon 52 (DMDΔ52) are a clinically severe model for DMD, mimicking molecular, functional and pathological hallmarks of the ...
Michaela Blasi +17 more
wiley +1 more source
The population genetics of Duchenne: natural and artificial selection in Duchenne muscular dystrophy. [PDF]
James Edwards
openalex +1 more source
Longitudinal interaction between muscle impairments and gait pathology in growing children with Duchenne muscular dystrophy. [PDF]
Vandekerckhove I +7 more
europepmc +1 more source
Protriptyline treatment of sleep hypoxaemia in Duchenne muscular dystrophy. [PDF]
Phil E M Smith +2 more
openalex +1 more source
Gene and RNA Editing: Revolutionary Approaches to Treating Diseases
The image illustrates gene editing technologies: DNA editing using CRISPR–Cas9 and RNA editing via Cas13d, with their clinical applications and ethical risks. DNA editing allows precise gene modifications for conditions like amyotrophic lateral sclerosis [ALS] and Huntington's disease, while RNA editing supports multiplexed modifications.
Jia‐Mei Li +6 more
wiley +1 more source
RFLP for Duchenne muscular dystrophy cDNA clone 44-1 [PDF]
Nigel G. Laing +7 more
openalex +1 more source

